Search

everythinglearnresearchcommunity

for

Search:↓

Using 10% topical minoxidil, oral finasteride, and microneedling together can effectively treat Male Pattern Baldness with high patient satisfaction and no major side effects.

Microneedling is generally safe but can cause minor, temporary side effects and requires caution for some patients.

Low-level light therapy safely improves hair coverage, thickness, and count in androgenetic alopecia patients.

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

Oral dutasteride improves hair growth, reduces hair loss, and is safe for most patients.

Both 0.01% and 0.03% bimatoprost safely improve eyebrow fullness, with a patient preference for the 0.03% concentration.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

The device effectively and safely increased hair growth in people with Androgenetic Alopecia.

PRP and minoxidil are similarly effective for hair density, but PRP has higher patient satisfaction.

The 1927-nm fractionated thulium laser treatment significantly improves hair thickness and count in pattern hair loss patients.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Finasteride is not proven to cause depression or suicide, and careful patient monitoring is advised.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Lurasidone is effective for bipolar depression and schizophrenia, but more safety data is needed.

A few users dominate Reddit discussions on JAK inhibitors, highlighting social media's potential for tracking drug safety but needing expert oversight.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Proper guidance on minoxidil use is crucial for effective results and safety.

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

Oral minoxidil effectively promotes hair growth in men with hair loss, but caution is needed for older or heart-risk patients.

A new wearable device stops hair loss and boosts hair growth safely.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

WS PRO 160 I 120 mg effectively treats urinary symptoms from BPH with good safety and tolerability.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

The document concludes that doctors should carefully consider off-label drug use in dermatology and always inform patients, while more research is needed on the safety and effectiveness of such practices.

CGRP MAbs treatment for migraines may also improve rosacea symptoms, but more research is needed to confirm its effectiveness and safety.

Understanding and careful application of dermabrasion and microdermabrasion can minimize risks and improve patient outcomes.

Leukocyte-rich platelet-rich plasma is safe and can potentially help treat scarring hair loss.

Biofibre ® 4.0 hair implants are safe and satisfy most patients with hair loss.

The combination of oral minoxidil, oral dutasteride, and mesotherapy is the most effective and safe for hair growth in AGA.

Oral betamethasone mini-pulses effectively treat moderate to severe alopecia areata with manageable side effects.